Pulmonx Corporation
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Pulmonx Corporation's yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Debt Due Cover Ratio: Operating cash was negative last year, while some debt falls due within a year. Lower than 95% of Healthcare companies in United States.
- Tangible Assets Ratio: Of every $100 the company owns, $98 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles. More tangible than 85% of Healthcare companies in United States.
- Steadiness Ratio: Sales grew in 3 of the last 3 years; profit grew in 2 of 3. Steadier than 85% of Healthcare companies in United States.
Where $100 of sales goes
Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
-37.5×Over the last 3 years operating cash was negative while the company kept spending on investment (capex).
Lower than 68% of Healthcare companies in United States.
Cash Locked Ratio
$26For every $100 of sales, $26 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $40 tied up three years earlier.
More money tied up than 55% of Healthcare companies in United States.
Growth quality
Steadiness Ratio
3/3 · 2/3Sales grew in 3 of the last 3 years; profit grew in 2 of 3.
Steadier than 85% of Healthcare companies in United States.
Growth Efficiency Ratio
$13Sales grew 69% in 3 years; of every extra $100 of sales, $13 became extra profit.
Lower than 56% of Healthcare companies in United States.
Asset Productivity Ratio
+69% / -33%In 3 years sales changed by +69% while total assets changed by -33%. Sales grew faster than assets.
Balance-sheet strength
Debt Due Cover Ratio
-305.4×Operating cash was negative last year, while some debt falls due within a year.
Lower than 95% of Healthcare companies in United States.
Cash Cushion Ratio
+17%Cash, after subtracting all debt, equals 17% of its market value (net cash).
Higher than 59% of Healthcare companies in United States.
Tangible Assets Ratio
98%Of every $100 the company owns, $98 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
More tangible than 85% of Healthcare companies in United States.
Tangible Net Worth Ratio
96%Of every $100 of net worth, $96 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
More tangible than 82% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (13)
Pulmonx Corporation made a loss over the last year. Pulmonx Corporation owes $0.66 for every $1 it owns. Pulmonx Corporation made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossPulmonx Corporation made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
2.06The share price is 2.06 times Pulmonx Corporation's book value per share, lower than 58% of Healthcare companies in United States.
Market cap
$81 MThe total market value of all of Pulmonx Corporation's shares at today's price (share price × number of shares), smaller than 68% of Healthcare companies in United States. PosiCap size class: Micro Cap.
Net worth (book value)
$39 MWhat Pulmonx Corporation would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$0.91Net worth divided by the number of shares. The share price of $1.88 is 2.1 times this, which is the P/B above.
Return on equity (ROE)
-88.9%Pulmonx Corporation lost 88.9% of its shareholders' money over the last year, lower than 67% of Healthcare companies in United States.
Owes vs Owns
0.66×Pulmonx Corporation owes $0.66 for every $1 it owns (moderate), higher than 69% of Healthcare companies in United States.
Dividend yield
NonePulmonx Corporation does not currently pay a dividend.
Revenue growth
+8%Revenue rose 8% in the year to Dec 2025, and grew 19% a year on average over 3 years.
Profit growth
LossPulmonx Corporation made a loss in each of the last two years.
Profit margin
-59.7%Pulmonx Corporation lost $60 for every $100 of revenue.
Interest cover
Not coveredPulmonx Corporation's operating profit did not cover its interest costs in the year to Dec 2025.
Cash vs debt
Net cashPulmonx Corporation held $13 M more cash than debt (net cash) at Dec 2025.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Pulmonx Corporation: $81 M ÷ $39 M (30 Jun 2026) = 2.1.
What is Pulmonx Corporation's return on equity?
Pulmonx Corporation lost 88.9% of its shareholders' money over the last year, lower than 67% of Healthcare companies in United States.
How much does Pulmonx Corporation owe compared with what it owns?
Pulmonx Corporation owes $0.66 for every $1 it owns (moderate), higher than 69% of Healthcare companies in United States.
Does Pulmonx Corporation pay a dividend?
No. Pulmonx Corporation does not currently pay a dividend.
Is Pulmonx Corporation's revenue growing?
Revenue rose 8% in the year to Dec 2025, and grew 19% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.